Patent Assignment
Reel/Frame 053184/0734
Change of Name
Recorded: 2020-07-10
Pages: 4
Assignor
BOSTON BIOMEDICAL, INC.
Executed: 2020-07-01
Assignee
SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(3)
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
Application:
62/870,415 →
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
Application:
62/888,149 →
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
Application:
62/934,167 →
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 22, 2019
From: SYNGENE INTERNATIONAL LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 050787/0323 →
Assignment of Assignor's Interest
Oct 22, 2019
From: BEARSS, DAVID J.; SIDDIQUI-JAIN, ADAM; WARNER, STEVEN L.; WHATCOTT, CLIFFORD J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 050786/0702 →
Assignment of Assignor's Interest
Oct 22, 2019
From: SEENISAMY, JEYAPRAKASH NARAYANAN
To: SYNGENE INTERNATIONAL LIMITED
Reel/Frame 050787/0131 →
Corrective Assignment to Correct the Correct Conveying Party Name Previously Recorded at Reel: 050787 Frame: 0131. Assignor(S) Hereby Confirms the Assignment.
Nov 12, 2019
From: SEENISAMY, JEYAPRAKASHNARAYANAN
To: SYNGENE INTERNATIONAL LIMITED
Reel/Frame 050989/0058 →
Assignment of Assignor's Interest
Jan 6, 2020
From: SYNGENE INTERNATIONAL LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051422/0763 →
Assignment of Assignor's Interest
Jan 6, 2020
From: BEARSS, DAVID J.; SIDDIQUI-JAIN, ADAM; WARNER, STEVEN L.; WHATCOTT, CLIFFORD J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051422/0618 →
Assignment of Assignor's Interest
Jan 6, 2020
From: SEENISAMY, JEYAPRAKASHNARAYANAN
To: SYNGENE INTERNATIONAL LIMITED
Reel/Frame 051422/0667 →
Merger
Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053173/0089 →
Change of Name
Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059810/0102 →